The goal of this program is to develop clinical scientists capable of conducting translational research through the integration of biomedical and pharmaceutical sciences and clinical expertise.

The program focuses on developing basic research skills that facilitate evaluation of mechanisms of disease processes and drug therapy. Dissertation projects must include both laboratory and clinical components. Students utilize preclinical models and conduct patient-oriented research to evaluate mechanisms of disposition, efficacy, and toxicity of therapeutic agents. In addition, ongoing clinical experience and advanced coursework in pharmacotherapy are integral to this program. The division has strengths in the following therapeutic areas: oncology, infectious diseases/HIV, cardiology, and gastroenterology/hepatology. Core coursework includes advanced pharmacotherapy, pharmacokinetics, pharmacodynamics, pharmacogenomics, molecular biology, biostatistics, and analytical methodology.